The findings suggest clinicians don’t need to be as aggressive in lowering BP in this population, at least early after ...
Daniel Burkhoff and Akshay Desai discuss the innovative technologies and late-breaking science presented at day 2 of THT.
Amid late-breaking coronary, structural, and endovascular trials will be a keynote from President Biden, and more.
Patients already had high NT-proBNP levels at baseline, though, raising questions about the quality of GDMT, Nancy Sweitzer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results